Literature DB >> 6141500

Functional studies with the opioid peptide dynorphin: acute effects of injections into the substantia nigra reticulata of naive rats.

M Herrera-Marschitz, T Hökfelt, U Ungerstedt, L Terenius.   

Abstract

When injected into the substantia nigra reticulata of naive rats, dynorphin-(1-17) caused a dose dependent contralateral rotation which was inhibited by naloxone in a dose dependent manner. Met-enkephalin injected in the same coordinates as the ones used with dynorphin also induced rotation but of lower intensity, while Leu-enkephalin did not elicit any significant response at the doses tested. D-amphetamine, injected subcutaneously 60 min after dynorphin, significantly enhanced the contralateral rotation induced by the intranigral administration of dynorphin. Experiments with dynorphin injections combined with D-amphetamine suggest that the dynorphin effects are mediated by neuronal loops involving dynorphin dopamine interactions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6141500     DOI: 10.1016/0024-3205(83)90563-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Rotational behaviour produced by intranigral injections of bovine and human beta-casomorphins in rats.

Authors:  M Herrera-Marschitz; L Terenius; L Grehn; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

3.  Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.

Authors:  M Herrera-Marschitz; I Christensson-Nylander; T Sharp; W Staines; M Reid; T Hökfelt; L Terenius; U Ungerstedt
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

4.  The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.

Authors:  M P Hill; J M Brotchie
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.